Company Profile
Updated: 23-SEP-09Curis Inc.
Public Company, Headquarters Location
45 Moulton St., Cambridge, MA 02138-1118, United States
(617)503-6500, (617)503-6501 fax, http://www.curis.com
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Services: Bio research and therapeutic drug development. Manufacturing: Pharmaceuticals preparations.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Curis to Present at Lazard Capital Markets Annual Healthcare Conference.(Conference news)
Health & Beauty Close-Up; 11/17/2009; 550 words; Curis, Inc., a drug development company seeking to...release, the Company noted that Dan Passeri, Curis' President and Chief Executive Officer...developed in Phase II clinical trials by Curis' collaborator Genentech, including in...
News and FDA Updates for Curis (NASDAQ:CRIS), PPD (Nasdaq:PPDI).
M2 Presswire; 11/12/2009; 954 words; ...BiomedReports: News and FDA Updates for Curis (NASDAQ:CRIS), PPD (Nasdaq...BioMedReports.Com On 11/11/09, Curis, Inc. (NASDAQ:CRIS), a drug development...York City. On 11/11/09, PPD, Inc. (Nasdaq:PPDI) announced its board...
Curis to Present at Lazard Capital Markets 6th Annual Healthcare Conference.(Conference news)
Business Wire; 11/11/2009; 694 words; CAMBRIDGE, Mass. -- Curis, Inc. (NASDAQ: CRIS), a drug development company seeking...section of the Curis website at www.curis.com. About Curis, Inc. Curis is a drug development company that is committed to...
Curis to Present at the Oppenheimer 20th Annual Healthcare Conference.(Conference news)
Cancer Weekly; 11/10/2009; 958 words; Curis, Inc. (NASDAQ: CRIS), a drug development...Waldorf Astoria in New York City (see also Curis, Inc.). Dan Passeri, Curis' President and...Curis website at www.curis.com. About Curis, Inc. Curis is a drug development company that...
Curis Reports Third Quarter 2009 Financial Results.(Financial report)
Cancer Weekly; 11/10/2009; 2004 words; Curis, Inc. (NASDAQ:CRIS), a drug development...quarter ended September 30, 2009 (see also Curis, Inc.). "The third quarter of 2009 was significant for Curis, as we entered into a license agreement...
Recent News Articles
- Curis Inc - Therapeutic Competitors.
M2 Presswire - June 22, 2009 - Curis, Inc. (NASDAQ: CRIS) Stock on the Move!
M2 Presswire - June 10, 2009 - Curis, Inc. (NASDAQ: CRIS) Hot Stock on the Move!
M2 Presswire - May 13, 2009 - Curis, Inc. - Financial and Strategic Analysis Review.
M2 Presswire - May 04, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
%20manufacturing%20%20&custom5=%20ma%20&position=1)